The use of migraine medications in workers’ compensation prescriptions, despite the overall cost per claim decreasing, a new report shows.
The first part of Enlyte’s 2025 Drug Trends Report released this week shows and migraine medications and topicals are gaining ground as alternatives to pain management, while opioid utilization continued to decline across all categories, including sustained-release opioids.
While opioids continue to be the most-prescribed drug class in workers’ comp, decreased by 7.8% in 2024. The frequency of opioid prescriptions are followed by SAIDs, anticonvulsants, muscle relaxants and topicals. The five classes represent the majority